Genesis HealthCare (GEN) Tops Q4 EPS by 1c; offers guidance

Genesis HealthCare (NASDAQ: GEN) reported Q4 EPS of $0.53, $0.01 better than the analyst estimate of $0.52. Revenue for the quarter came in at $967 million versus the consensus estimate of $965.03 million.

GUIDANCE:

Genesis HealthCare sees Q1 2025 EPS of $0.52-$0.54, versus the consensus of $0.53. Genesis HealthCare sees Q1 2025 revenue of $960-970 million, versus the consensus of $965.2 million.

Genesis HealthCare sees FY2025 EPS of $2.17-$2.23, versus the consensus of $2.22. Genesis HealthCare sees FY2025 revenue of $3.89-3.93 billion, versus the consensus of $3.939 billion.

For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Oracle (ORCL) Tops Q4 EPS by 16c, Offers Guidance
• Limoneira (LMNR) Misses Q2 EPS by 8c, Beats on Revenue